These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 18833404

  • 21. Efficacy and safety of intravenous moxifloxacin versus cefoperazone with azithromycin in the treatment of community acquired pneumonia.
    Xu S, Xiong S, Xu Y, Liu J, Liu H, Zhao J, Xiong W.
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(4):421-4. PubMed ID: 17120738
    [Abstract] [Full Text] [Related]

  • 22. Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia.
    File TM, Low DE, Eckburg PB, Talbot GH, Friedland HD, Lee J, Llorens L, Critchley I, Thye D.
    Clin Infect Dis; 2010 Dec 15; 51(12):1395-405. PubMed ID: 21067350
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial.
    Lloyd A, Holman A, Evers T.
    Curr Med Res Opin; 2008 May 15; 24(5):1279-84. PubMed ID: 18358083
    [Abstract] [Full Text] [Related]

  • 30. Clinical efficacy and safety of a short regimen of azithromycin sequential therapy vs standard cefuroxime sequential therapy in the treatment of community-acquired pneumonia: an international, randomized, open-label study.
    Kuzman I, Daković-Rode O, Oremus M, Banaszak AM.
    J Chemother; 2005 Dec 15; 17(6):636-42. PubMed ID: 16433194
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Azithromycin versus comparative therapy for the treatment of community acquired pneumonia.
    Rahav G, Fidel J, Gibor Y, Shapiro M.
    Int J Antimicrob Agents; 2004 Aug 15; 24(2):181-4. PubMed ID: 15288319
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia?
    Sánchez F, Mensa J, Martínez JA, García E, Marco F, González J, Marcos MA, Soriano A, Torres A.
    Clin Infect Dis; 2003 May 15; 36(10):1239-45. PubMed ID: 12746768
    [Abstract] [Full Text] [Related]

  • 35. Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults.
    Drehobl MA, De Salvo MC, Lewis DE, Breen JD.
    Chest; 2005 Oct 15; 128(4):2230-7. PubMed ID: 16236879
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Gatifloxacin in the treatment of community-acquired pneumonias: a comparative trial of ceftriaxone, with or without macrolides, in hospitalized adult patients with mild to moderately severe pneumonia.
    Mendonça JS, Yamaguti A, Corrêa JC, Badaró R.
    Braz J Infect Dis; 2004 Feb 15; 8(1):90-100. PubMed ID: 15286880
    [Abstract] [Full Text] [Related]

  • 40. [Efficacy and safety of azithromycin infusion in patients with mild or moderate community-acquired pneumonia].
    Noguchi S, Yatera K, Kawanami T, Yamasaki K, Uchimura K, Hata R, Tachiwada T, Oda K, Hara K, Suzuki Y, Akata K, Ogoshi T, Tokuyama S, Inoue N, Nishida C, Orihashi T, Yoshida Y, Kawanami Y, Taura Y, Ishimoto H, Obata H, Tsuda T, Yoshii C, Mukae H.
    Jpn J Antibiot; 2014 Jun 15; 67(3):193-203. PubMed ID: 25163252
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.